Page 4 - Femy Yong News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Femy yong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Femy Yong Today - Breaking & Trending Today
Femasys Inc. (NASDAQ:FEMY – Free Report) was the recipient of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 13,000 shares, a decline of 50.0% from the May 31st total of 26,000 shares. Currently, 0.1% of the shares of the company are sold short. […] ....
Femasys (NASDAQ:FEMY – Get Rating) had its target price reduced by stock analysts at Chardan Capital from $12.00 to $10.00 in a research report issued on Thursday, The Fly reports. Femasys Price Performance Shares of NASDAQ:FEMY traded down $0.05 during trading on Thursday, reaching $1.15. The company had a trading volume of 2,446 shares, compared […] ....
Investment analysts at Maxim Group assumed coverage on shares of Femasys (NASDAQ:FEMY – Get Rating) in a research report issued on Friday, Stock Target Advisor reports. The firm set a “buy” rating and a $5.00 price target on the stock. Maxim Group’s target price would suggest a potential upside of 284.62% from the stock’s previous […] ....
Femasys (NASDAQ:FEMY – Get Rating) is one of 216 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Femasys to similar companies based on the strength of its dividends, valuation, earnings, profitability, institutional ownership, analyst recommendations and risk. Valuation & Earnings This table compares […] ....
Femasys (NASDAQ:FEMY – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Femasys Inc.is a biomedical company focused on transforming women’s healthcare by developing novel solutions as well as providing significant clinical […] ....